Results 121 to 130 of about 1,397,577 (212)

Editor's note: EIC farewell and new EIC introduction

, 2013
Editor's note: EIC farewell and new EIC ...
Ivan Stojmenovic (13054578)
core  

Erratum: Editor's note. [PDF]

Bioact Mater
europepmc   +2 more sources

From the Editor

Journal of Montessori Research
Angela Murray
doaj   +1 more source

APOBEC3 activity and DNA polymerase‐ε deficiency are associated with distinct IDH1 R132 hotspot mutations

Molecular Oncology, EarlyView.
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler, Bilal A. Lone, Ecem Unal, A. Rouf Banday   +3 more
wiley   +1 more source

Editor's note and ad hoc reviewers for 2010

, 2011
Editor's note and ad hoc reviewers for ...
Sue Wright (13214419), Greg Clinch (13226109), Asher Curtis (14582564), Paul Coram (14210567), Jason Hall (3472706), Christine Jubb (13511743), Subhash Abhayawansa (13511746), Sue Taylor (14582597), Colin Anderson (14582549), Kathie Cooper (14582561), Ahsan Habib (512151), Christine Petrovits (14582591), Grace Hsu (8920556), Nava Subramaniam (13376325), Stuart Tooley (14582603), Fawzi Laswad (14582582), Lori Holder-Webb (14582567), Madhu Veeraraghavan (13348929), Andrew Worthington (3030954), Irene Tutticci (14582606), Irene Tempone (14582600), Richard Petty (3851002), Robyn Pilcher (14582594), Marie Kavanagh (14582579), Farshid Navissi (13598080), Kym Boon (14582558), Jodie Nelson (14582588), Keryn Chalmers (13552630), Bryan Howieson (14582570), Cameron Truong (13348926), Rachel Baskerville (14582552), Shamsul Abdullah (14582546), Irene Kim (4451116), Helen Irvine (14582576), Helen Kang (11128316), Marion Hutchinson (14582573), Janice Loftus (14582585), Pam Kent (7110659), Jacqueline Birt (14582555)   +38 more
core  

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

Molecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault, Capucine Heraud, Mélissa Correia de Oliveira, Véronique Neaud, Valérie Valesco, Valérie Prouzet‐Mauleon, Béatrice Turcq, Jean‐William Dupuy, Anne‐Aurélie Raymond, Sabrina Croce, Frédéric Saltel, Valérie Lagrée, Violaine Moreau   +12 more
wiley   +1 more source

Editor's Note on 'Protein Syndesmos is a novel RNA-binding protein that regulates primary cilia formation'. [PDF]

Nucleic Acids Res
Sale JE, Stoddard BL.
europepmc   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

Molecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim, Aurelie Genoux, Nadiia Zubchuk, Haoyang Zheng, Perla Salameh, Theo Ziegelmeyer, Fabien Dalonneau, Margot Rouchette, Christiane Oddou, Simona Miron, Helene Polveche, Adiilah Mamode Cassim, Carmen Garrido, Eleni Nikolakaki, Didier Auboeuf, Tao Jia, Sophie Zinn‐Justin, Beatrice Eymin   +17 more
wiley   +1 more source

Women's Poetry: 2011

ABO : Interactive Journal for Women in the Arts 1640-1830, 2011
Laura Runge
doaj  

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba, Mark Shacker, Timothy P. Fleming, Michael A. Smith, Ross M. Bremner, Narendra V. Sankpal   +5 more
wiley   +1 more source